iDose® TR

At Southwest Eye Institute in El Paso, our glaucoma specialists are proud to offer iDose® TR, a breakthrough glaucoma treatment implant.

What is iDose TR?

iDose TR is FDA-approved microscopic implant for treating open-angle glaucoma and ocular hypertension. This tiny device continuously releases glaucoma medication (travoprost) inside your eye for an extended period. Unlike daily eye drops, iDose TR works continuously as a “slow-release” reservoir within the eye’s drainage system, effectively reducing intraocular pressure and protecting the optic nerve.

It’s placed during a quick in-office procedure and slowly releases medication over time to help keep eye pressure under control. iDose TR can last up to three years before it needs to be replaced. When that time comes, your glaucoma specialist can safely remove it and replace it with a new one if needed.
Play Video
iDose TR YouTube thumbnail.

Benefits of iDose TR for Glaucoma Patients

Choosing iDose TR means embracing a more proactive and convenient way to manage glaucoma. Key benefits and advantages include:

iDose TR eliminates the need for daily glaucoma drops, offering freedom from the disruption and difficulty of remembering them.

The implant provides continuous therapy to keep eye pressure steady. Unlike drops that can wear off or be missed, iDose TR remains active, providing stable pressure control and enhanced optic nerve protection over time.

Studies show it can maintain eye pressure for 2-3 years with a single implant. Many patients avoid additional glaucoma drops for at least 12 months, bringing prolonged control and peace of mind.

Internal delivery can reduce irritation and redness, with most side effects being mild and uncommon.

The iDose TR treatment is a minimally invasive, outpatient procedure. It does not require a hospital stay. Your ophthalmologist performs it in an outpatient surgical suite or office setting. It takes only a few minutes per eye and is described by patients as “painless or with minimal discomfort”, since the eye is thoroughly numbed with anesthetic drops beforehand. There are no stitches needed, and the tiny incision is self-sealing.

You can resume normal activites within days. Consult with your eye doctor for aftercare.

iDose TR is undetectable and doesn’t affect vision, comfort, or appearance.

Who Is a Good Candidate for iDose TR?

iDose TR is generally recommended for adults with open-angle glaucoma (OAG) or ocular hypertension who require lower eye pressure and who would benefit from a sustained-release treatment. Here are some indicators that you might be an ideal candidate:
  • Have open-angle glaucoma or ocular hypertension
  • Struggle with daily glaucoma eye drops
  • Experience side effects from topical medications
  • Want a long-term, low-maintenance glaucoma treatment
  • Need more consistent pressure control
  • Certain eye conditions may make iDose TR unsuitable, which is why a personalized evaluation with a glaucoma specialist is essential.
It’s important to have a thorough evaluation with a glaucoma specialist to determine candidacy. We will review your corneal health (to ensure no endothelial issues that could be affected), angle anatomy, and overall eye condition. If iDose TR is not suitable, we have many other glaucoma treatment options available. Your safety and optimal outcome are our top priorities.
Play Video
Video thumbnail

iDose diagram of what the implant looks like on a finger. It's so small.The iDose TR Procedure: What to Expect

One of the remarkable aspects of iDose TR is how quick and simple the procedure is for patients. Here’s an overview of what you can expect when undergoing an iDose TR implantation at Southwest Eye Institute:

Consultation & Evaluation

First, our glaucoma specialist will conduct a comprehensive eye exam to confirm that you are a suitable candidate for iDose TR. We’ll review your glaucoma type (it must be open-angle glaucoma or ocular hypertension for iDose TR to be indicated—open-angle glaucoma means the eye’s drainage angles are open but fluid exits too slowly; ocular hypertension means you have high eye pressure without optic nerve damage) and discuss your current treatments. If you have been struggling with daily drops or still have elevated eye pressure despite treatment, you might be an ideal candidate. We’ll also check for any disqualifying conditions – for example, patients with active eye infections, certain corneal conditions (like endothelial cell dystrophy, a disease of the cornea’s inner lining, or a prior corneal transplant), or very narrow angles (where the drainage angle is too tight for implantation) may not be eligible for an implant. Your doctor will determine the best course and ensure iDose TR is safe for you.

Before the Procedure

On the day of the procedure, no extensive preparation is needed. It’s typically done under local/topical anesthesia. You will be awake, but your eye will be numbed with drops and perhaps a mild sedative given to keep you relaxed. The procedure is usually done one eye at a time (if both eyes need it, they might be done on separate visits or sometimes the same day, depending on the surgeon’s plan).

Insertion of the Implant

The surgeon will use a special injector tool to place the implant. A tiny incision (microscopic in size) is made at the edge of the cornea (clear front of the eye). Through this opening, the preloaded iDose TR device is gently inserted into the front chamber of the eye. The actual implantation takes only a few minutes.

Outpatient & Same-Day Discharge

After a brief post-procedure observation, you’ll be able to go home the same day with no hospital stay needed. The incision is so small that it generally self-seals without stitches. Your doctor will cover your eye with a protective shield or patch for a short time, and you’ll be given specific eye drops to use for a couple of weeks to aid healing (ironic as it sounds, some temporary drops like anti-inflammatories or antibiotics ensure the implant settles in without issues).

Recovery

Recovery time is usually fast. Most patients resume their normal daily activities within a day or two after the procedure. You may experience mild redness, irritation, or a sandy feeling in the operated eye for a few days. We will schedule follow-up visits to check your eye pressure and make sure the iDose implant is positioned correctly (it’s very rare, but if the implant were to move or dislocate, the doctor can detect it and reposition or remove it if needed. Serious complications are uncommon; however, as with any eye procedure, we’ll monitor for signs of infection, inflammation, or significant pressure changes in the early weeks. Our team will give you clear instructions on post-op care. Generally, you’ll use some prescription eye drops (such as anti-inflammatory drops) temporarily during healing, but the goal is that you won’t need your chronic glaucoma drops anymore on a daily basis.

Follow-Up Care

After iDose TR, we will continue to see you at regular intervals to ensure your intraocular pressure remains at target and your glaucoma is stable. While iDose TR often reduces or eliminates the need for glaucoma drops, there is currently no cure for glaucoma and you will still need ongoing monitoring. The implant’s effect is intended to last years, but individual results vary. Some patients may still need a regimen of one drop or need additional treatments down the line, and others may eventually get a replacement implant when the time comes. We will tailor your care plan to your needs. Many patients feel empowered knowing that a huge part of their glaucoma management is now “hands-off” and handled by this tiny device.

Contact Southwest Eye Institute in El Paso today

Imagine the freedom of not having to use multiple eye drops every day; no more stinging, no more worrying if you forgot a dose, and no more juggling prescription refills. iDose TR can simplify your life and give you confidence that your treatment is on track, even when you’re busy or asleep. Many patients describe feeling a weight lifted off their shoulders after getting the implant, as their daily fight with glaucoma becomes much easier to manage.